Industry

Serum Institute plans to start vaccine production outside India: The Times

Adar Poonawalla  

The Serum Institute of India, which manufactures the AstraZeneca COVID-19 vaccine, is planning to start vaccine production in other countries as it struggles to meet supply commitments, its chief executive officer told The Times.

"There's going to be an announcement in the next few days,"Adar Poonawalla was quoted as saying by the newspaper in an interview published on Friday.

Mr. Poonawalla said last week that the Serum Institute would be able to raise its monthly output to 100 million doses by July, later than a previous timeline of end-May. Several states have run out of vaccines against COVID-19.

He hoped to increase the Serum Institute's production capacity from 2.5 billion to 3 billion doses a year within six months, the Times reported, adding that he flew to London before Britain banned travellers from India eight days ago.

Coronavirus cases and deaths have surged in India. The surge has led to a public health crisis and forced the government to seek oxygen, medicines and other essentials from abroad.

The nation's coronavirus cases may peak between May 3-5, according to scientists advising the government.


Our code of editorial values

Related Topics
This article is closed for comments.
Please Email the Editor

Printable version | Jun 14, 2021 12:06:37 AM | https://www.thehindu.com/business/Industry/serum-institute-plans-to-start-vaccine-production-outside-india-the-times/article34455835.ece

Next Story